No Data
Express News | Summary of Shareholding changes on December 24.
Express News | Beihai Gofar Chuanshan Biological: Acting Director Jiang Ye plans to increase his Shareholding to 30 million yuan to 60 million yuan.
Express News | A new way for listed companies to auction equity: multiple parties take action and deeply "link" to the secondary market.
China Development Stock Report for the Third Quarter of 2024
Beihai Gofar Chuanshan Biological (600538.SH) announced the performance for the first three quarters, with a net loss of 20.88 million yuan.
Beihai Gofar Chuanshan Biological (600538.SH) disclosed the third quarter report for 2024, and the company achieved operating income in the first three quarters...
Beihai Gofar Chuanshan Biological (600538.SH): The net loss in the first three quarters was 20.8826 million yuan.
Gelonghui October 29th | Beihai Gofar Chuanshan Biological (600538.SH) announced that in the first three quarters of 2024, the revenue was 0.263 billion yuan, a decrease of 6.99% year-on-year; the net income attributable to the shareholders of the listed company was -20.8826 million yuan, with a basic earnings per share of -0.04 yuan.
